ZBIO - Company ID 0001953926
The table below shows Zenas BioPharma, Inc.'s balance sheet line items across its last 2 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 |
|---|---|---|
| Cash & equivalents | $110.64M | $319.74M |
| Short-term investments | $232.55M | $31.02M |
| Receivables | - | - |
| Inventory | - | - |
| Total current assets | $351.17M | $355.92M |
| Property, plant & equipment | $34.00K | $185.00K |
| Goodwill | - | - |
| Total assets | $383.64M | $369.97M |
| Accounts payable | $7.11M | $17.14M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current liabilities |
| $62.65M |
| $57.29M |
| Long-term debt | $78.64M | - |
| Total liabilities | $141.50M | $57.51M |
| Retained earnings | -$765.13M | -$387.39M |
| Total equity | $242.14M | $312.46M |